Vitalhub (TSE:VHI – Get Free Report) had its price objective cut by stock analysts at TD from C$13.00 to C$9.50 in a research note issued on Monday, BayStreet reports. The brokerage presently has a “buy” rating on the stock. TD‘s price target indicates a potential upside of 41.16% from the company’s previous close.
Other analysts have also issued research reports about the stock. Canaccord Genuity Group set a C$15.00 price objective on shares of Vitalhub and gave the company a “buy” rating in a research note on Friday, August 28th. ATB Cormark Capital Markets reduced their price target on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating for the company in a report on Monday. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Vitalhub presently has a consensus rating of “Moderate Buy” and an average target price of C$10.86.
Check Out Our Latest Stock Report on VHI
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 earnings per share (EPS) for the quarter. The firm had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. On average, research analysts predict that Vitalhub will post 0.23 earnings per share for the current year.
Key Stories Impacting Vitalhub
Here are a few of the latest stories about VHI:
- Neutral Sentiment: A Seeking Alpha article discusses Vitalhub digesting acquisitions while preparing for more; the headline points to acquisition execution and future deals as areas for investors to monitor. Vitalhub: Digesting Acquisitions While Preparing For More
- Negative Sentiment: Royal Bank of Canada downgraded Vitalhub from “moderate buy” to “hold,” also reported as a shift to “sector perform.” The downgrade adds a cautious signal amid the broader round of reduced price targets. Vitalhub Downgraded to Sector Perform at RBC
- Negative Sentiment: All seven other named firms cut their targets, including Scotia to C$9.00 from C$12.00 and TD to C$9.50 from C$13.00. Although their ratings remain positive, the reductions suggest analysts have tempered their expectations. TD analyst coverage
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
